Research sets global standard for Crohn’s treatment
Trial results published by Cambridge researchers earlier this year and involving patients at Addenbrooke’s Hospital are helping to set new global standards for the treatment of…
Team praised for “game-changing” heart trial
A senior Addenbrooke’s early phase trials researcher has praised patients, staff and sponsors who backed a landmark trial which could be a “game changer” in the battle to…
Improving outcomes for Crohn's patients
Treating newly-diagnosed patients with advanced therapy leads to dramatic improvements in outcomes.
Roll out of Cambridge-developed artificial pancreas is world first
An artificial pancreas developed with the help of staff and patients at Addenbrooke's Hospital is one of four new devices to be rolled out by the NHS - helping…
New clues about irritable bowel syndrome found in the brain
Breakthrough research led by Addenbrooke's Hospital gives IBS patients like Laura Tebbs a better understanding of their condition.
Researchers eye up new gene therapy trial that could reverse hereditary blindness
Restoration of sight from a rare genetic mutation may now become a reality thanks to a prestigious award from the National Institute for Health Research (NIHR) and Moorfields…
Covid-19 treatment trial for kidney patients goes national
An Addenbrooke’s trial is rolling out to hospitals across the UK to see if a drug used to treat tapeworm can give high-risk kidney patients extra protection against Covid-19.…
The PROTECT-V trial investigating UNIONs COVID-19 candidate receives Urgent Public Health…
UNION therapeutics A/S (UNION) today announced that the National Institute for Health Research (NIHR) in the UK has granted Urgent Public Health (UPH) prioritization to the…
Trials to find preventative COVID-19 treatments for most vulnerable to launch in UK
Two new clinical trials to develop treatments to prevent people catching (coronavirus) COVID-19 are to launch in the UK.
Dr Rona Smith leads Covid trial starting with tapeworm drug
Cambridge University Hospitals NHS Foundation Trust is leading a major new trial to discover whether a drug used to treat tapeworms can prevent high risk kidney patients…
Dex-CSDH study outcomes published in the New England Journal of Medicine
Outcomes of a trial of Dexamethasone for Chronic Subdural Hematoma has been published in the …
CAMPROBE study reveals differences in patterns of prostate cancer treatment in England
There are widespread differences in the way hospitals across the country treat men with prostate cancer.
Summary of TACTIC-E protocol published by BMC
A structured summary of a study protocol for a randomised controlled trial of Repurposed immunomodulatory drugs for Covid-19 in pre-ICu patients - muLTi-Arm Therapeutic…
Cancer patients could benefit from world class web tool
Research using a sophisticated web tool, which is being carried out with help from doctors and patients at Addenbrooke’s Hospital, could lead to cancer patients receiving…
Summary of TACTIC-R protocol published by BMC
A structured summary of a study protocol for a randomised controlled trial of Repurposed immunomodulatory drugs for Covid-19 in pre-ICu patients - mulTi-Arm Therapeutic…
Cambridge University Hospitals group launches experimental drug trial to treat Covid-19
Cambridge University Hospitals group is launching a fast-turnaround experimental drug trial to treat Covid-19.
COVID-19 research taking place at CUH
Latest update from Professor John Bradley, Director of the NIHR Cambridge Biomedical Research Centre on COVID-19 research at Cambridge University Hospitals.
New trial seeks to improve survival rates for patients with COVID-19
A new trial is taking place at Addenbrooke’s Hospital to test whether COVID-19 patients with weak immune systems have a better chance of survival if they are injected with…
Rapid coronavirus test speeds up access to urgent care
Cambridge university researchers have analysed the impact of using point-of-care testing at Addenbrooke's hospital.
Cambridge study to trial widely used drug to protect healthcare staff from COVID-19
The PROLIFIC study (ChemoPROphyLaxIs For covId-19 infeCtious disease) aims to determine whether hydroxychloroquine (HCQ), a widely used anti-malarial drug, is effective at…
Trial launched testing existing drugs in bid to treat coronavirus patients
Treating Covid-19 patients may change after a nationwide trial…
National trial launched to find Covid-19 treatment
A new trial to prevent organ failure and death in Covid-19 patients is being launched led by clinicians and scientists in Cambridge, and at King’s College London.
Over 150 participants recruited to new COVID-19 research programme
A “library” of valuable biological samples from people with COVID-19, which will help scientists globally fight the virus, has recruited its 150th participant.
Genetic analysis reveals new causes of Primary Immunodeficiency (PID)
A UK-wide research collaboration through the NIHR BioResource for Rare Diseases has combined whole genome sequencing with a statistical program called BeviMed to predict the…
Protocol of CLOuD of published in the BMJ
A research protocol for a randomised parallel study assessing the effect of closed-loop insulin delivery from onset of type 1 diabetes in youth on residual beta-cell…
Research staff begin working on new COVID-19 study
Research staff from NIHR Cambridge Clinical Research Facility (CRF) are being deployed onto the wards at Cambridge University Hospitals (CUH) to start using a new test for a…
Adapted care for cancer patients due to COVID-19
The Cancer Research UK Cambridge Centre and six other leading European cancer centres share knowledge and experiences to define new guidelines for treating cancer patients…
Rapid COVID-19 diagnostic test developed by Cambridge team to be deployed in hospitals
A new rapid diagnostic test for COVID-19, developed by a University of Cambridge spinout company and capable of diagnosing the infection in under 90 minutes, is being deployed…
First CUH patient in national Covid-19 Trial
Cambridge University Hospitals NHS Foundation Trust has today (Friday, 27 March) enrolled its first patient into a national trial aimed at identifying treatments for Covid-19…
Team effort achieves accreditation
Cambridge University Hospitals, as part of the Cancer Research UK Cambridge Centre, has achieved re-accreditation by the Organisation of European Cancer Institutes (OECI) as a…
COVID-19 research studies at CUH
In response to the COVID-19 pandemic Cambridge University Hospitals has put in place measures to help researchers and research infrastructure deliver COVID-19 studies, while…
Update on clinical research during the COVID-19 outbreak from CUH
As part of our response to COVID-19, some of our research activity will need to change. We are reviewing all of our clinical research with Cambridge University Hospitals (CUH)…
Global health worker shortage prompts partnership action
A Cambridge partnership is taking action in the face of a predicted shortfall of 18 million health workers globally in the next decade.
Findings of PEXIVAS published in the NEJM
Findings of a global trial of plasma exchange and steroid dosing in autoimmune vasculitis (PEXIVAS) have recently been …
New NIHR Cambridge BRC Director Appointed at CUH
The NIHR Cambridge Biomedical Research Centre (BRC) has announced Dr Miles Parkes will be the new director of the centre, based at Cambridge University Hospitals (CUH).
Protocol for Dex-CSDH published by BMC
A corrected protocol for a trial of dexamethasone for adult patients with a symptomatic chronic subdural haematoma (Dex-CSDH) has recently been…
The EudraCT Tool
The CCTU is pleased to launch the EudraCT Tool which was developed by our Lead Senior Statistician, Dr Simon Bond, in collaboration with colleagues from Birmingham,…
ICN Chair and Vice-Chair Elected
We are pleased to announce the appointment of the new ICN Chairperson, Thomas Hiemstra, and Vice Chair-person, Henry Yau.
CCTU Launches New Website
Collaboratively developed with Isle Interactive and hosted by Red Graphic
